The New York State Psychiatric Institute
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1895-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.nyspi.org
Electronic Cigarettes or Nicotine Inhaler for Smoking Cessation
Not Applicable
Withdrawn
- Conditions
- Tobacco Use Disorder
- Interventions
- Other: electronic cigarette
- First Posted Date
- 2013-12-09
- Last Posted Date
- 2016-10-19
- Lead Sponsor
- New York State Psychiatric Institute
- Registration Number
- NCT02004171
- Locations
- 🇺🇸
Substance Treatment and Research Services (STARS), New York, New York, United States
Vilazodone for Separation Anxiety Disorder
- First Posted Date
- 2013-12-03
- Last Posted Date
- 2018-03-07
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 24
- Registration Number
- NCT01999920
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
A Sequenced Behavioral and Medication Intervention for Cocaine Dependence
Phase 1
Completed
- Conditions
- Cocaine Dependence
- Interventions
- Behavioral: Computer-assisted behavior therapyDrug: Mixed-Amphetamine Salts- Extended Release (MAS-ER)Drug: Placebo
- First Posted Date
- 2013-11-18
- Last Posted Date
- 2022-01-25
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 145
- Registration Number
- NCT01986075
- Locations
- 🇺🇸
STARS, New York, New York, United States
Transcranial Magnetic Stimulation for Evaluation and Treatment of Repetetive Behaviors in Autism
Phase 2
Terminated
- Conditions
- Asperger DisorderAutismOther Developmental Pervasive Disorder
- Interventions
- Procedure: transcranial magnetic stimulation
- First Posted Date
- 2013-11-13
- Last Posted Date
- 2017-03-24
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 10
- Registration Number
- NCT01983189
- Locations
- 🇺🇸
New York State Psychiatric Institute, 1051 Riverside Drive, New York, New York, United States
Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older Adults
Phase 4
Completed
- Conditions
- Dysthymic DisorderDepressive Disorder, NOSMajor Depressive Disorder
- Interventions
- Drug: Antidepressant Medication
- First Posted Date
- 2013-10-31
- Last Posted Date
- 2021-01-29
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 100
- Registration Number
- NCT01973283
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
Prescription Opioid Abuse Among Pain Patients: Predictors of Relapse
Phase 2
Completed
- Conditions
- Opioid Dependence
- Interventions
- Drug: buprenorphine/naloxone combination
- First Posted Date
- 2013-10-23
- Last Posted Date
- 2019-04-24
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 51
- Registration Number
- NCT01967641
- Locations
- 🇺🇸
SURC, New York, New York, United States
Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly
Phase 4
Completed
- Conditions
- Delirium, Dementia, Amnestic, Cognitive DisordersAlzheimer DiseaseMild Cognitive Impairment
- Interventions
- First Posted Date
- 2013-09-26
- Last Posted Date
- 2020-07-13
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 121
- Registration Number
- NCT01951118
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
Personalized and Scalable Cognitive Remediation Approaches
Not Applicable
Completed
- Conditions
- SchizophreniaSchizoaffective Disorder
- Interventions
- Behavioral: Cognitive remediation
- First Posted Date
- 2013-09-18
- Last Posted Date
- 2020-09-16
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 122
- Registration Number
- NCT01945333
- Locations
- 🇺🇸
FEGS Bronx Mental Health Clinic, Bronx, New York, United States
🇺🇸Williamsburg Clinic, Brooklyn, New York, United States
🇺🇸Institute for Community Living, Brooklyn, New York, United States
Ketamine for Suicidality in Bipolar Depression
Phase 1
Completed
- Conditions
- Suicidal IdeationBipolar DisorderMajor Depressive Episode
- Interventions
- First Posted Date
- 2013-09-17
- Last Posted Date
- 2020-03-11
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 16
- Registration Number
- NCT01944293
- Locations
- 🇺🇸
Columbia University/New York State Psychiatric Institute, New York, New York, United States
A Comparison of Medication Augmentation and PST in the Treatment of Depression in Older Adults
Phase 4
Withdrawn
- Conditions
- Depressive Disorder Not Otherwise Specified (NOS)Major Depressive DisorderDysthymic Disorder
- Interventions
- First Posted Date
- 2013-09-13
- Last Posted Date
- 2019-04-18
- Lead Sponsor
- New York State Psychiatric Institute
- Registration Number
- NCT01942187
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath